Non-Invasive Ventilation With Helmets for Acute Respiratory Distress Due to COVID-19

This Health Technology Update newsletter describes patient helmets, also known as “helmet masks,” and their potential use in COVID-19 infection control. These helmets are designed to reduce the risk of COVID-19 transmission from infected patients to health care providers and other patients. The newsletter provides a background to the technology, target populations, cost and availability, […]

Ongoing Trials of Plasma-Based Therapies for the Treatment of COVID-19

This report provides information on ongoing randomized controlled trials of intravenous immune globulin and hyperimmune globulin that are being investigated for the management of COVID-19. It will be updated every month. Ongoing trials of convalescent plasma are addressed in separate CADTH reports Link to Report Ongoing Trials of Plasma-Based Therapies for the Treatment of COVID-19 […]

What You Should Know About Drug Treatments for COVID-19

CADTH created this handout, intended for the general public, explaining the risks of using unproven drug treatments for COVID-19. The handout also provides information on what to do if someone is experiencing COVID-19 symptoms, tips on how to assess the reliability of health information found on the internet, and a list of reliable websites that […]

Rapid Point-of-Care Antigen Testing for SARS-CoV-2 Infection

This newsletter explores recent developments in testing for COVID-19. Testing for COVID-19 infection is important to stopping spread of the virus. There is also a need for tests that can quickly provide results. Evidence related to rapid point-of-care antigen testing — such as current practice, availability in Canada, cost, and safety — are summarized in […]

Heating, Ventilation, and Air Conditioning Systems in Public Spaces

This report reviews evidence related to airflow transmission of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the risk associated with the use of heating, ventilation and air conditioning (HVAC) systems. A targeted literature review along with a multidisciplinary expert panel discussion were the primary approaches to examine the evidence. More robust, published, peer-reviewed evidence is […]

Ongoing Trials for Drugs in the Prevention and Treatment of COVID-19

This report provides information on ongoing randomized controlled trials of drugs being investigated to treat or prevent COVID-19. It will be updated every two weeks. Ongoing trials of vaccines and plasma-based therapies are addressed in separate CADTH reports. Link to Report Ongoing Trials for Drugs in the Prevention and Treatment of COVID-19 (Updated September 16, […]

Remdesivir Implementation Panel

Remdesivir (Veklury) is authorized by Health Canada to treat patients with severe COVID-19 symptoms who have pneumonia and need extra oxygen to help them breathe. The drug is administered intravenously and is only to be used in health care facilities where patients can be closely monitored. CADTH is convening an implementation panel of clinical specialists […]

Enablers for Virtual Visits

The COVID-19 pandemic has forced the widespread use of virtual visits, demonstrating that care can be delivered effectively through virtual means. As the risk of transmission and exposure to the virus remain, and as patient demand for virtual access to health care providers is unlikely to abate over the immediate term and beyond, the health […]

Triage Tools and Management Algorithms for Colorectal Cancer Screening: Guidelines

CADTH conducted a Rapid Response Report to search for evidence-based guidelines regarding the use of stool-based screening tests, screening triage tools, or management algorithms for colorectal cancer screening. However, no relevant evidence-based guidelines were identified in these searches. Link to Report Triage Tools and Management Algorithms for Colorectal Cancer Screening: Guidelines

Tocilizumab for the Treatment and Prevention of COVID-19: A Review of Clinical Effectiveness

Tocilizumab (TCZ), a recombinant humanized monoclonal antibody, used for severe rheumatoid arthritis and life-threatening cytochrome release syndrome, may be a potential treatment option for COVID-19 infection. Patients with severe COVID-19 infection showed an increase in pro-inflammatory cytokines; hence, it was thought that blocking the receptor of these agents may reduce the inflammatory response to COVID-19. […]

CADTH Emerging Health Technology for COVID-19: Sarilumab

Sarilumab is an interleukin-6 receptor antagonist indicated, in Canada, for rheumatoid arthritis and has been identified as a potential option for treating COVID-19. Two published studies were identified in the CADTH Horizon Scan that evaluated the efficacy and safety of sarilumab for the treatment of COVID-19. Link to Report CADTH Emerging Health Technology for COVID-19: […]

Remdesivir: Evidence Review and Appraisal

CADTH conducted a Health Technology Review on remdesivir — an antiviral drug currently being used to treat COVID-19. Remdesivir was approved in Canada on July 27, 2020 to treat adults and adolescents with severe symptoms of COVID-19 who have pneumonia and require extra oxygen. Four randomized controlled trials were identified and included in the review. […]